Total Payments
$5,345
2024 Payments
$801.98
Companies
17
Transactions
265
Medicare Patients
1,090
Medicare Billing
$116,748
Payment Breakdown by Category
Food & Beverage$5,157 (96.5%)
Education$187.67 (3.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,157 | 257 | 96.5% |
| Education | $187.67 | 8 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,718 | 74 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,198 | 46 | $0 (2024) |
| Lundbeck LLC | $445.80 | 31 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $349.11 | 31 | $0 (2020) |
| ABBVIE INC. | $319.36 | 23 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $274.87 | 9 | $0 (2024) |
| Allergan, Inc. | $226.85 | 16 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $191.42 | 5 | $0 (2024) |
| Alkermes, Inc. | $180.70 | 7 | $0 (2021) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $178.57 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $801.98 | 25 | Otsuka America Pharmaceutical, Inc. ($222.62) |
| 2023 | $178.47 | 5 | Otsuka America Pharmaceutical, Inc. ($99.38) |
| 2022 | $599.50 | 32 | Otsuka America Pharmaceutical, Inc. ($172.59) |
| 2021 | $813.23 | 45 | Otsuka America Pharmaceutical, Inc. ($274.32) |
| 2020 | $647.66 | 28 | Otsuka America Pharmaceutical, Inc. ($377.93) |
| 2019 | $604.26 | 41 | Otsuka America Pharmaceutical, Inc. ($213.02) |
| 2018 | $788.39 | 39 | Janssen Pharmaceuticals, Inc ($198.07) |
| 2017 | $911.64 | 50 | Janssen Pharmaceuticals, Inc ($349.65) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $63.80 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $14.24 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $74.99 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.62 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: PSYCHIATRY | ||||||
| 06/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: PSYCHIATRY | ||||||
| 06/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $146.91 | General |
| Category: Neuroscience | ||||||
| 05/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: PSYCHIATRY | ||||||
| 05/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: PSYCHIATRY | ||||||
| 05/16/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: PSYCHIATRY | ||||||
| 04/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $52.99 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 02/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: PSYCHIATRY | ||||||
| 01/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 227 | 665 | $104,599 | $29,881 |
| 2022 | 5 | 308 | 810 | $113,545 | $31,960 |
| 2021 | 5 | 312 | 916 | $114,863 | $41,184 |
| 2020 | 5 | 243 | 612 | $46,344 | $13,723 |
Total Patients
1,090
Total Services
3,003
Medicare Billing
$116,748
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 218 | $56,114 | $16,572 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 183 | $33,266 | $10,350 | 31.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 70 | 239 | $13,969 | $2,020 | 14.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 25 | $1,250 | $939.84 | 75.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 250 | $62,975 | $18,737 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 145 | $27,485 | $7,850 | 28.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 84 | 297 | $16,719 | $2,673 | 16.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 31 | 80 | $4,000 | $2,217 | 55.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 38 | 38 | $2,367 | $483.65 | 20.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 324 | $77,770 | $28,537 | 36.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 100 | $16,035 | $6,389 | 39.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 95 | 378 | $15,102 | $3,472 | 23.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 34 | 83 | $4,150 | $2,321 | 55.9% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 29 | 31 | $1,806 | $465.75 | 25.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 93 | 153 | $24,721 | $5,737 | 23.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 40 | 97 | $4,850 | $3,016 | 62.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 77 | 324 | $11,173 | $2,679 | 24.0% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2020 | 17 | 19 | $3,458 | $1,803 | 52.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 16 | 19 | $2,143 | $486.97 | 22.7% |
About Dr. Ali Ibrahim, M.D
Dr. Ali Ibrahim, M.D is a Psychiatry healthcare provider based in Saginaw, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710089388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali Ibrahim, M.D has received a total of $5,345 in payments from pharmaceutical and medical device companies, with $801.98 received in 2024. These payments were reported across 265 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($5,157).
As a Medicare-enrolled provider, Ibrahim has provided services to 1,090 Medicare beneficiaries, totaling 3,003 services with total Medicare billing of $116,748. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Saginaw, MI
- Active Since 09/02/2006
- Last Updated 09/28/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1710089388
Products in Payments
- REXULTI (Drug) $1,230
- INVEGA SUSTENNA (Drug) $1,006
- ABILIFY MAINTENA (Drug) $811.85
- VRAYLAR (Drug) $515.84
- LATUDA (Drug) $349.11
- CAPLYTA (Drug) $211.46
- INGREZZA (Drug) $191.42
- SPRAVATO (Drug) $176.68
- UZEDY (Drug) $125.00
- ARISTADA (Drug) $102.51
- BRINTELLIX (Drug) $93.43
- Aristada 441 mg (Drug) $78.19
- AUSTEDO (Drug) $73.62
- TRINTELLIX (Drug) $72.85
- Trintellix (Drug) $68.83
- BELSOMRA (Drug) $67.25
- VIBERZI (Drug) $19.22
- Auvelity (Drug) $18.93
- HETLIOZ (Drug) $16.19
- INVEGA TRINZA (Drug) $15.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saginaw
Dr. Kaushik Raval, M.d, M.D
Psychiatry — Payments: $88,974
Psychiatry $88,974
Mr. Nicholas Lazurka, (Pa-C), (PA-C)
Psychiatry — Payments: $4,816
Psychiatry $4,816
Ryan Cox, M.d, M.D
Psychiatry — Payments: $4,418
Psychiatry $4,418
Mrs. Hema Talasila, M.d, M.D
Psychiatry — Payments: $4,351
Psychiatry $4,351
Dr. Chalichama Rao, M.d, M.D
Psychiatry — Payments: $2,053
Psychiatry $2,053
Samantha Grosteffon
Psychiatry — Payments: $943.34
Psychiatry $943.34